Carregant...
Beneficial Effect of Adjuvant Dabrafenib Plus Trametinib on Recurrence-Free Survival in Patients With Resected BRAF(V600)-Mutant Stage III Melanoma Seems to be Short-Lived
Guardat en:
| Publicat a: | J Clin Oncol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Clinical Oncology
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524987/ https://ncbi.nlm.nih.gov/pubmed/30939097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01768 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|